| Drug Name |
Codeine sulfate |
| Drug ID |
BADD_D00517 |
| Description |
The relief of pain (analgesia) is a primary goal for enhancing the quality of life of patients and for increasing the ability of patients to engage in day to day activities. Codeine, an opioid analgesic, was originally approved in the US in 1950 and is a drug used to decrease pain by increasing the threshold for pain without impairing consciousness or altering other sensory functions. Opiates such as codeine are derived from the poppy plant, _Papaver somniferum_ (Papaveraceae).[A175096]
Codeine is utilized as a central analgesic, sedative, hypnotic, antinociceptive, and antiperistaltic agent, and is also recommended in certain diseases with incessant coughing.[LABEL,A175096] |
| Indications and Usage |
For treatment and management of pain (systemic). It is also used as an antidiarrheal and as a cough suppressant. |
| Marketing Status |
Not Available |
| ATC Code |
R05DA04 |
| DrugBank ID |
DB00318
|
| KEGG ID |
D03580
|
| MeSH ID |
D003061
|
| PubChem ID |
5359613
|
| TTD Drug ID |
D03DIG
|
| NDC Product Code |
0527-1698; 0527-1699; 0406-1580; 0054-0245; 0054-0243; 0054-0244 |
| Synonyms |
Codeine | Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)- | N-Methylmorphine | N Methylmorphine | Isocodeine | Codeine Phosphate | Ardinex |
